Oberweis Asset Management’s NeoGenomics NEO Stock Holding History

Oberweis Asset Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-768,700	Closed	-$12.7M	–	203
2024 Q4	$12.7M	Buy	768,700 +50,000	+7%	+$777K	0.6%	68
2024 Q3	$10.6M	Buy	718,700 +50,000	+7%	+$782K	0.54%	66
2024 Q2	$9.27M	Sell	668,700 -68,500	-9%	-$971K	0.57%	66
2024 Q1	$11.6M	Buy	737,200 +344,500	+88%	+$5.32M	0.84%	37
2023 Q4	$6.35M	Buy	392,700 +99,300	+34%	+$1.62M	0.59%	58
2023 Q3	$3.61M	Buy	293,400 +80,400	+38%	+$1.2M	0.38%	105
2023 Q2	$3.42M	Buy	+213,000	New	+$3.51M	0.42%	98
2019 Q3	–	Sell	-17,300	Closed	-$380K	–	207
2019 Q2	$380K	Sell	17,300 -23,300	-57%	-$511K	0.07%	160
2019 Q1	$831K	Sell	40,600 -24,100	-37%	-$419K	0.17%	93
2018 Q4	$816K	Buy	+64,700	New	+$964K	0.18%	92
2017 Q1	–	Sell	-121,700	Closed	-$1.04M	–	148
2016 Q4	$1.04M	Buy	121,700 +6,900	+6%	+$59.1K	0.31%	59
2016 Q3	$944K	Buy	114,800 +37,800	+49%	+$317K	0.27%	61
2016 Q2	$619K	Buy	+77,000	New	+$617K	0.18%	84

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Oberweis Asset Management's NEO Position: Q1 2025 in Review

Oberweis Asset Management sold out of NeoGenomics (NEO) in Q1 2025, closing a stake of 768,700 shares — an estimated $12.7M sold.

Oberweis Asset Management first reported a position in NEO in Q2 2016 and held it in 13 quarters. The position peaked at $12.7M in Q4 2024. 256 funds tracked by Wall St. Rank hold NEO as of Q1 2025.

Oberweis Asset Management reported no remaining NeoGenomics position as of Q1 2025 after selling out during the quarter.
Oberweis Asset Management sold 768,700 NeoGenomics shares in Q1 2025, an estimated $12.7M.
Oberweis Asset Management first reported a position in NeoGenomics in Q2 2016 and held it in 13 quarters.
Oberweis Asset Management's NeoGenomics position peaked at $12.7M in Q4 2024.
256 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2025.

Based on Oberweis Asset Management's 13F filing for Q1 2025, filed 15 May 2025.